ANTI-MYOSIN AND ANTI-RHABDOMYOBLAST SERA - THEIR USE FOR THE DIAGNOSIS OF CHILDHOOD RHABDOMYOSARCOMA
- 1 January 1980
- journal article
- research article
- Vol. 104 (3), 118-122
Abstract
Antisera against myosin of human normal skeletal muscle and against rhabdomyoblasts of autopsy-proved rhabdomyosarcoma were raised in white rabbits, purified and assessed for their usefulness in the diagnosis of childhood rhabdomyosarcoma. The specificity of the antisera was tested by immunofluorescence and immunoperoxidase methods in 7 cases of autopsy-proven rhabdomyosarcoma, 5 of malignant lymphoma, 3 of neuroblastoma and 2 of Ewing''s sarcoma. Antimyosin serum tested positive for all cases of rhabdomyosarcoma and negative for other types of tumor. Antirhabdomyoblast serum was positive in all cases of rhabdomyosarcoma and cross-reacted with cases of neuroblastoma and Ewing''s tumor, although the intensity of staining was much decreased. Antimyosin serum is specific for childhood rhabdomyosarcoma and can be used to differentiate this from other childhood round cell tumors.This publication has 2 references indexed in Scilit:
- A Putatively new Antigen (CSAp) Associated with Gastrointestinal and Ovarian NeoplasiaImmunological Communications, 1977
- Technical Factors Affecting the Preparation of Fluorescent Antibody ReagentsThe Journal of Immunology, 1961